The feasibility of Enteral Nutrition (EN) support in Allogeneic Haematopoietic Stem Cell Transplantation.

Not Applicable

Recruiting

• Conditions: Hematologic Neoplasms; Enteral Nutrition; Cancer - Leukaemia - Acute leukaemia; Cancer - Leukaemia - Chronic leukaemia; Cancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphoma

• Registration Number: ACTRN12619000942156
• Lead Sponsor: Shannon Petrovic

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-07-05
• Last Update Posted: 15 July 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Patients undergoing an initial MAC or RIC allogeneic stem cell transplant for a Haematological Malignancy
Patients >18 years old

Exclusion Criteria

Patients who have previously received a MAC or RIC allogeneic stem cell transplant

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The severity of gastrointestinal symptoms measured using the Memorial Symptom Assessment Scale, a paper-based questionnaire to be completed by the patient.[Assessed at baseline (Day 0 transplant), Day 7, Day 14, Day 21 and Day 28];The percentage of total possible amount of enteral feeds delivered, assessed by referring to the electronic fluid balance chart completed by nursing staff within the patient's medical record. [Assessed on discharge.]